T
Tvardi Therapeutics, Inc. (TVRD)
NCM – Real Time Price. Currency in USD
1.50
-0.86 (-36.44%)
At close: Jun 26, 2026, 4:00 PM EDT
1.88
+0.38 (25.33%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.50
-0.86 (-36.44%)
At close: Jun 26, 2026, 4:00 PM EDT
1.88
+0.38 (25.33%)
After-hours: Jun 26, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $19.9M significantly exceed its total debt $174.0K, ensuring strong financial flexibility
Total current assets $25.3M exceed Total current liabilities $11.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$5.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.25 | 6.05 | 10 | |
| Quick ratio | 2.25 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 42M | 21M | N/A | N/A | N/A |
| Gross Profit | 34M | 15M | -95K | -95K | -119K |
| Operating Income | -88M | -121M | -28M | -27M | -29M |
| Net Income | -85M | -119M | -29M | -18M | -15M |
| EBITDA | -86M | -121M | -28M | -27M | -29M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 29.56 | 5.5 |
| Next quarter | N/A | -4.9 | 1.0 |
| Current year | N/A | 22.19 | 5.5 |
| Next year | N/A | -5.17 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 6.47 | 6.41 | -3.05 | 5.3 |
| Y/Y | 999 | 28.97 | 77.33 | 23.8 | 10 |
| 3y average | 283.03 | 24.87 | -17.57 | 10.79 | 7.0 |
| 5y average | 169.59 | -214.72 | -222.14 | -185.77 | 3.3 |
| Weighted average score | 6.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |